Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CVS
CVS logo

CVS Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
72.740
Open
72.060
VWAP
72.32
Vol
1.61M
Mkt Cap
91.37B
Low
71.820
Amount
116.48M
EV/EBITDA(TTM)
8.54
Total Shares
1.27B
EV
145.51B
EV/OCF(TTM)
13.68
P/S(TTM)
0.23
CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, PDPs and Medicaid health care management services. The Health Services segment provides a full range of pharmacy benefit management (PBM) solutions through its CVS Caremark operations and delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its CVS Pharmacy retail locations and, through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise.
Show More

Events Timeline

(ET)
2026-03-30
12:10:00
CVS Health Opens First Pharmacy-Only Location in Chicago
select
2026-03-26 (ET)
2026-03-26
14:10:00
OpenAI Plans to Raise $10B, Nvidia-Backed Reflection Seeks $2.5B
select
2026-03-26
14:10:00
U.S. Justice Department Sues New York-Presbyterian Hospital for Antitrust Violations
select
link
2026-03-24 (ET)
2026-03-24
15:10:00
CVS Health Reaches Settlement with FTC on Insulin Pricing
select
link
2026-03-24
13:10:00
JPMorgan Analyst Says CVS Health Nears Settlement with FTC
select
2026-03-24
08:50:00
Sonoma Pharmaceuticals Launches Burn Relief Hydrogel in CVS and Walmart
select

News

Newsfilter
8.5
03-30Newsfilter
PinnedCVS Launches Community Pharmacies to Enhance Access
  • Community Pharmacy Openings: CVS Health plans to open nearly 20 pharmacy-only locations in 2026, starting with one in Chicago, aimed at enhancing residents' access to medications and immunization services, thereby improving community health service accessibility.
  • Customized Offerings: The new pharmacies will feature a tailored selection of over-the-counter products, with an average footprint of 3,000 square feet, ensuring patients can conveniently access prescription medications and professional pharmacist advice, which is expected to boost patient satisfaction and loyalty.
  • Diverse Pharmacy Formats: By introducing pharmacy-only locations alongside traditional pharmacies, in-store pharmacies, and MinuteClinics, CVS aims to meet the varied health needs of different communities while optimizing its retail footprint to adapt to industry shifts.
  • Importance of Face-to-Face Interactions: According to the 2025 CVS Health Rx Report, 80% of patients prefer in-person pharmacy care, and CVS is ensuring patients have multiple service options to choose from based on their individual needs, thereby enhancing overall service delivery.
CNBC
8.5
16:03 PMCNBC
Eli Lilly's GLP-1 Pill Approval Marks New Weight Loss Market Entry
  • Regulatory Milestone: The FDA's approval of Eli Lilly's GLP-1 pill, Foundayo, represents a significant advancement for the company in the weight-loss medication market, setting the stage for competition with Novo Nordisk's Wegovy and altering market dynamics.
  • Pricing Strategy: Foundayo is priced at $25 per month with insurance or between $149 and $349 out-of-pocket, aiming to attract a broader patient base, particularly appealing to seniors, thereby expanding the market for weight-loss drugs.
  • Global Market Expansion: Lilly plans to seek approval for Foundayo in over 40 countries within the next year, leveraging its small molecule nature to enable global production and distribution without cold-chain constraints, enhancing its competitive edge.
  • Sales Projections: Analysts estimate Foundayo's sales could reach $14.79 billion by 2030, although lower than Zepbound's $24.68 billion, it still indicates strong market potential and is seen as a key factor for Eli Lilly's stock recovery.
CNBC
8.5
03-31CNBC
Novo Nordisk Launches Wegovy Subscription Program for Obesity Treatment
  • Subscription Program Launch: Novo Nordisk launched a multi-month subscription program for its Wegovy obesity drug on Tuesday, aiming to provide cash-paying patients with lower and more predictable monthly prices, thereby enhancing patient adherence to therapy.
  • Pricing and Savings: The three-month subscription for the injection is priced at $329 per month, saving patients $240 annually, while the 12-month plan drops to $249 per month, allowing for savings of up to $1,200 per year, significantly easing the financial burden on patients.
  • Market Competition Pressure: As Novo's Wegovy drug experiences rapid uptake in the U.S. market, it is expected to face competition from an upcoming oral GLP-1 from Eli Lilly, which currently holds about 60% of the GLP-1 market share compared to Novo's 39%.
  • Patient Flexibility: Patients can opt out of the subscription while active, and Novo aims to help patients feel more comfortable managing obesity treatment in the long term, although the program is not yet available on its NovoCare platform.
moomoo
5.0
03-30moomoo
CVS Health to Open Pharmacy-Only Locations in Multiple Communities in 2026, Alongside New Site in Chicago
  • Pharmacy Locations: CVS Health is planning to open pharmacy-only locations in several communities in 2026, in addition to a new site in Chicago.
  • Community Focus: The initiative aims to enhance access to pharmacy services in various neighborhoods, reflecting a commitment to community health.
moomoo
5.0
03-30moomoo
CVS Health Launches Its First Pharmacy-Only Location in Chicago
  • CVS Pharmacy Launch: CVS has opened its first pharmacy-only location in Chicago, marking a new approach to its retail strategy.

  • Focus on Accessibility: The new pharmacy aims to enhance accessibility to pharmaceutical services for the local community.

  • Innovative Services: This location will offer a range of services tailored to meet the needs of patients, including medication management and consultations.

  • Expansion Plans: CVS plans to evaluate the success of this model for potential expansion to other urban areas in the future.

stocktwits
7.0
03-25stocktwits
CVS Health Reaches Proposed Settlement with FTC on Insulin Pricing
  • Settlement Progress: CVS Health's proposed settlement with the FTC is expected to be finalized in the coming weeks, modeled after a similar agreement with Cigna's Express Scripts, indicating the company's proactive stance on drug pricing transparency.
  • Stock Price Reaction: Following the settlement news, CVS Health shares rose 2% on Tuesday, reflecting market optimism about the agreement, with analysts suggesting that this resolution will alleviate uncertainties in the pharmacy benefit management sector, thereby boosting investor confidence.
  • Market Outlook: Leerink reiterated an 'Outperform' rating on CVS Health with a $98 price target, suggesting a potential upside of approximately 35% from Tuesday's closing price, indicating a positive market sentiment regarding the company's future performance.
  • Cost Reduction for Patients: The settlement with the FTC is expected to lower patients' out-of-pocket costs for insulin and other drugs by up to $7 billion over the next decade, highlighting CVS's strategic importance in advocating for drug price rationalization.
Wall Street analysts forecast CVS stock price to rise
17 Analyst Rating
Wall Street analysts forecast CVS stock price to rise
16 Buy
1 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
91.00
Averages
96.71
High
105.00
Current: 0.000
sliders
Low
91.00
Averages
96.71
High
105.00
Piper Sandler
Overweight
downgrade
$101 -> $99
AI Analysis
2026-03-31
New
Reason
Piper Sandler
Price Target
$101 -> $99
AI Analysis
2026-03-31
New
downgrade
Overweight
Reason
Piper Sandler lowered the firm's price target on CVS Health to $99 from $101 and keeps an Overweight rating on the shares. The firm updated its model to better conform with guidance and guidance commentary.
Leerink
Leerink
Outperform
maintain
$98
2026-03-24
Reason
Leerink
Leerink
Price Target
$98
2026-03-24
maintain
Outperform
Reason
Leerink said the report that CVS Health has likely reached a proposed settlement with the FTC isn't a major surprise. However, the firm added that completing any settlement is an incremental positive as it removes an "air of uncertainty" from a pharmacy benefit management business that has had numerous recent overhangs. Leerink reiterated an Outperform rating and $98 price target on CVS Health shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CVS
Unlock Now

Valuation Metrics

The current forward P/E ratio for CVS Health Corp (CVS.N) is 10.72, compared to its 5-year average forward P/E of 10.31. For a more detailed relative valuation and DCF analysis to assess CVS Health Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
10.31
Current PE
10.72
Overvalued PE
11.71
Undervalued PE
8.91

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
9.98
Current EV/EBITDA
26.33
Overvalued EV/EBITDA
14.00
Undervalued EV/EBITDA
5.95

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.29
Current PS
0.22
Overvalued PS
0.38
Undervalued PS
0.21

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

money market funds
Intellectia · 68 candidates
Market Cap: >= 1000.00MRegion: USBeta: LowRisk, NegativeBetaList Exchange: XNYS, XNAS, XASEYear Price Change Pct: $2.00 - $8.00Monthly Average Dollar Volume: >= 100,000
Ticker
Name
Market Cap$
top bottom
KO logo
KO
Coca-Cola Co
321.48B
PM logo
PM
Philip Morris International Inc
252.94B
T logo
T
AT&T Inc
201.96B
CB logo
CB
Chubb Ltd
126.84B
SO logo
SO
Southern Co
106.81B
DUK logo
DUK
Duke Energy Corp
100.69B
best stocks to short
Intellectia · 70 candidates
Market Cap: >= 1000.00MPe Ttm: >= 40List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceBelowMA200Annual Eps Yoy Growth: <= -10.0%Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
TSLA logo
TSLA
Tesla Inc
1.38T
SHOP logo
SHOP
Shopify Inc
152.29B
PANW logo
PANW
Palo Alto Networks Inc
132.97B
COF logo
COF
Capital One Financial Corp
112.86B
CEG logo
CEG
Constellation Energy Corp
102.16B
CVS logo
CVS
CVS Health Corp
90.94B
which has the highest return?
Intellectia · 14 candidates
Market Cap: >= 5.00BRegion: USPrice: $10.00 - $150.00One Day Rise Prob: >= 60One Day Predict Return: >= 3.0%Monthly Average Dollar Volume: >= 3,000,000
Ticker
Name
Market Cap$
top bottom
LNC logo
LNC
Lincoln National Corp
6.85B
CVS logo
CVS
CVS Health Corp
96.93B
RRR logo
RRR
Red Rock Resorts Inc
6.46B
PINS logo
PINS
Pinterest Inc
11.69B
MFC logo
MFC
Manulife Financial Corp
59.36B
QGEN logo
QGEN
Qiagen NV
10.06B
accion que comprar hoy para corto plazo
Intellectia · 399 candidates
Market Cap: >= 5.00BRsi Category: moderateList Exchange: XNYS, XNASMoving Average Relationship: PriceAboveMA20One Week Predict Return: >= 0.0%Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
SMFG logo
SMFG
Sumitomo Mitsui Financial Group Inc
134.12B
APG logo
APG
APi Group Corp
18.03B
SAN logo
SAN
Banco Santander SA
182.13B
CMI logo
CMI
Cummins Inc
78.93B
SMR logo
SMR
Nuscale Power Corp
5.98B
GDS logo
GDS
GDS Holdings Ltd
8.53B
which stock to pick tomorrow
Intellectia · 158 candidates
Relative Vol: >= 1.15Weekly Average Turnover: >= 1,000,000Moving Average Relationship: PriceAboveMA5Week Price Change Pct: >= $0.00
Ticker
Name
Market Cap$
top bottom
LLY logo
LLY
Eli Lilly and Co
1.02T
AMD logo
AMD
Advanced Micro Devices Inc
406.68B
CAT logo
CAT
Caterpillar Inc
302.02B
AMGN logo
AMGN
Amgen Inc
185.02B
SYK logo
SYK
Stryker Corp
138.80B
ETN logo
ETN
Eaton Corporation PLC
131.26B
best stocks in healthcare and energy
Intellectia · 20 candidates
Market Cap: >= 10.00BDividend Yield Ttm: >= 1Rsi 14: 55 - 65Week Price Change Pct: >= $0.00
Ticker
Name
Market Cap$
top bottom
CTRA logo
CTRA
Coterra Energy Inc
20.37B
AMGN logo
AMGN
Amgen Inc
185.02B
WMB logo
WMB
Williams Companies Inc
77.16B
GILD logo
GILD
Gilead Sciences Inc
160.18B
TRGP logo
TRGP
Targa Resources Corp
40.80B
UNH logo
UNH
UnitedHealth Group Inc
315.01B
which are stocks are good to buy tomorrow?
Intellectia · 98 candidates
Relative Vol: >= 1.40Weekly Average Turnover: >= 2,000,000Rsi 14: 40 - 60Week Price Change Pct: >= $0.00Month Price Change Pct: >= $0.00
Ticker
Name
Market Cap$
top bottom
LLY logo
LLY
Eli Lilly and Co
1.02T
UNH logo
UNH
UnitedHealth Group Inc
315.01B
MS logo
MS
Morgan Stanley
290.20B
GEV logo
GEV
GE Vernova Inc
181.21B
MDT logo
MDT
Medtronic PLC
128.57B
BTI logo
BTI
British American Tobacco plc
125.29B
which stock to buy for this week earnings
Intellectia · 213 candidates
Market Cap: >= 1000.00MBeta: LowRiskWeekly Average Turnover: >= 1,000,000Is Optionable: True
Ticker
Name
Market Cap$
top bottom
MCD logo
MCD
McDonald's Corp
217.70B
SHEL logo
SHEL
Shell PLC
209.17B
AMGN logo
AMGN
Amgen Inc
185.02B
SPGI logo
SPGI
S&P Global Inc
160.84B
PFE logo
PFE
Pfizer Inc
147.20B
SYK logo
SYK
Stryker Corp
138.80B
Add filter: beta < 1.5 and short float < 10%
Intellectia · 18 candidates
Market Cap: >= 10.00BDividend Yield Ttm: >= 3Short Ratio: LessThan10PctBeta: LowRisk, ModerateRisk
Ticker
Name
Market Cap$
top bottom
KO logo
KO
Coca-Cola Co
309.76B
MUFG logo
MUFG
Mitsubishi UFJ Financial Group Inc
206.98B
CVS logo
CVS
CVS Health Corp
103.45B
MFC logo
MFC
Manulife Financial Corp
62.58B
AMX logo
AMX
America Movil SAB de CV
62.47B
SU logo
SU
Suncor Energy Inc (Canada)
60.68B
what stocks are primed to breakout soon?
Intellectia · 610 candidates
Weekly Average Turnover: >= 1,000,000Rsi 14: 40 - 70Candlestick Pattern: WhiteCandlestickSupport Resistance Relationship: PriceBreakResistance
Ticker
Name
Market Cap$
top bottom
JNJ logo
JNJ
Johnson & Johnson
525.25B
HD logo
HD
Home Depot Inc
382.91B
KO logo
KO
Coca-Cola Co
309.76B
TMO logo
TMO
Thermo Fisher Scientific Inc
239.06B
APH logo
APH
Amphenol Corp
189.24B
AMGN logo
AMGN
Amgen Inc
185.02B

Whales Holding CVS

M
Maple Rock Capital Partners Inc.
Holding
CVS
+20.32%
3M Return
M
Mubadala Investment Company PJSC
Holding
CVS
+19.49%
3M Return
S
SAMA Foreign Holdings
Holding
CVS
+9.52%
3M Return
P
Polaris Capital Management, LLC
Holding
CVS
+9.51%
3M Return
H
Hamblin Watsa Investment Counsel Ltd.
Holding
CVS
+7.32%
3M Return
B
Braidwell LP
Holding
CVS
+6.39%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is CVS Health Corp (CVS) stock price today?

The current price of CVS is 72.4 USD — it has increased 0.81

What is CVS Health Corp (CVS)'s business?

CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, PDPs and Medicaid health care management services. The Health Services segment provides a full range of pharmacy benefit management (PBM) solutions through its CVS Caremark operations and delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its CVS Pharmacy retail locations and, through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise.

What is the price predicton of CVS Stock?

Wall Street analysts forecast CVS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CVS is96.71 USD with a low forecast of 91.00 USD and a high forecast of 105.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is CVS Health Corp (CVS)'s revenue for the last quarter?

CVS Health Corp revenue for the last quarter amounts to 105.69B USD, increased 8.17

What is CVS Health Corp (CVS)'s earnings per share (EPS) for the last quarter?

CVS Health Corp. EPS for the last quarter amounts to 2.29 USD, increased 76.15

How many employees does CVS Health Corp (CVS). have?

CVS Health Corp (CVS) has 300000 emplpoyees as of April 01 2026.

What is CVS Health Corp (CVS) market cap?

Today CVS has the market capitalization of 91.37B USD.